+499.5%
MRNA vs CRBG
+3.6%
+495.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CRBG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.8% | -1.4% | -2.0% |
| 7D | +5.5% | +5.7% | -0.2% | +4.1% |
| 30D | +158.7% | +2.6% | +156.1% | +157.0% |
| 3M | +182.1% | +31.6% | +150.5% | +148.4% |
| 6M | +151.8% | +32.8% | +119.0% | +118.8% |
| YTD | +393.6% | +16.5% | +377.1% | +347.6% |
| 1Y | +499.5% | +6.1% | +493.4% | +473.8% |
| All | +499.5% | +3.6% | +495.9% | +473.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CRBG.
Daily Out/Under-Performance
Portfolio return minus CRBG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CRBG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CRBG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling